Radiotherapy-related lymphopenia affects overall survival in patients with lung cancer
AffiliationDivision of Cancer Sciences, The University of Manchester, Manchester, United Kingdom;
MetadataShow full item record
AbstractIntroduction: Lymphopenia following radiotherapy has an adverse effect on patient's outcome. However, the relationship between radiotherapy dose delivery and lymphopenia is not fully understood. This work is utilizing image-based data mining to identify anatomical regions where the received dose is correlated with severe lymphopenia. Methods: 901 lung cancer patients were analyzed. A Cox model was used to assess prognostic factors of overall survival (OS). Two matched groups were defined-patients with and without lymphopenia?G3-based on tumor volume, baseline lymphocytes, and delivered dose. Then, data mining was used to identify regions where dose correlates significantly with lymphopenia?G3. For this, dose matrices were aligned using registration of the computed tomography (CT) images to one reference patient. Mean dose distributions were obtained for the two groups and organs of significance were detected. Dosimetric parameters from the identified organs that had the highest correlation with lymphocytes at nadir were selected. Multivariable analysis was conducted for lymphopenia?G3 on the full lung cohort and the model was tested on 305 esophageal cancer patients. Results: Adjusted Cox regression showed that lymphopenia?G3 was an independent factor of OS. The anatomical regions identified were heart, lung, and thoracic vertebrae. Dosimetric parameters for lymphopenia included vertebrae V20, mean lung dose and, mean heart dose which was further validated in the esophageal cancer cohort. Conclusions: We have shown severe lymphopenia during radiotherapy is a significant poor prognostic factor for OS in lung cancer patients and could be mitigated by minimizing vertebrae V20, mean lung and heart dose to limit irradiation of stem cells and blood pool. Keywords: Image-based data mining; chemoradiotherapy; esophageal cancer; lung cancer; lymphopenia; radiotherapy.
CitationAbravan A, Faivre-Finn C, Kennedy J, McWilliam A, van Herk M. Radiotherapy-related lymphopenia affects overall survival in patients with lung cancer. J Thorac Oncol. 2020.
JournalJournal of Thoracic Oncology
- Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy.
- Authors: Abravan A, Eide HA, Helland Å, Malinen E
- Issue date: 2020 May
- Spleen Dose-Volume Parameters as a Predictor of Treatment-related Lymphopenia During Definitive Chemoradiotherapy for Esophageal Cancer.
- Authors: Saito T, Toya R, Yoshida N, Shono T, Matsuyama T, Ninomura S, Watakabe T, Sasaki Y, Baba H, Oya N
- Issue date: 2018 Nov-Dec
- Post-treatment lymphocytopaenia, integral body dose and overall survival in lung cancer patients treated with radical radiotherapy.
- Authors: Joseph N, McWilliam A, Kennedy J, Haslett K, Mahil J, Gavarraju A, Mistry H, Van Herk M, Faivre-Finn C, Choudhury A
- Issue date: 2019 Jun
- The Impact of Lymphopenia and Dosimetric Parameters on Overall Survival of Esophageal Cancer Patients Treated with Definitive Radiotherapy.
- Authors: Liu M, Li X, Cheng H, Wang Y, Tian Y
- Issue date: 2021
- Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy?
- Authors: Ma JT, Sun L, Sun X, Xiong ZC, Liu Y, Zhang SL, Huang LT, Han CB
- Issue date: 2017 Feb 1